Biohaven

Biohaven is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing treatments in neuroscience, immunology, and oncology. It currently operates as a pre-commercial pipeline company with no meaningful product revenue and relies on research, clinical development, and financing activities to advance its candidates.

Relationship details are part of the Pro plan.